SEC Form 4 · accession 0001161697-15-000197
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald A Denkhaus
Director
Period of report
Apr 27, 2015
Accepted (ET)
Apr 28, 2015 · 8:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Apr 27, 2015 | P | 15,000 | $3.71 | A | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.